← Browse by Condition
Medical Condition
recurrent medulloblastoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT04501718 Phase 2
Recruiting
Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Enrollment
44 pts
Location
China
Sponsor
Beijing Sanbo Brain Hospital
NCT07087002 Phase 1
Recruiting
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Enrollment
18 pts
Location
United States
Sponsor
Stanford University